Announced Wed, 15 Jul · 18:26 IST
Board meeting on Aug 6, 2026 to consider Q1 FY27 results
Results View source PDF
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹1792.00
prior close
₹1794.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.5-0.6-0.1-0.4+3.9+7.8+4.9+4.5+6.9————
Up moveDown movePending
AI summary
Emcure Pharmaceuticals has scheduled a Board meeting on August 6, 2026 to consider and approve Unaudited Financial Results, both standalone and consolidated, for Q1 FY27 (quarter ended June 30, 2026). The trading window for designated persons and their relatives is closed from July 1, 2026 till August 8, 2026 (48 hours after results are declared), per the company's insider trading code under SEBI PIT Regulations.
Likely market impact
Routine pre-results filing. Q1 FY27 earnings due after the August 6 board meeting; watch for revenue growth, margin trends and any guidance.